Literature DB >> 30391418

Adverse pregnancy outcomes among pregnant women with acute Rubella infections in Mwanza city, Tanzania.

Mariam M Mirambo1, Said Aboud2, Mtebe Majigo2, Uwe Groβ3, Stephen E Mshana4.   

Abstract

OBJECTIVE: This study investigated the adverse pregnancy outcomes among pregnant women with acute Rubella infections in the city of Mwanza, Tanzania.
METHODS: A longitudinal study was conducted between 2014 and 2016 among pregnant women attending antenatal clinics. Women were screened for Rubella IgG and IgM antibodies using enzyme immunoassay (EIA). IgM seropositive pregnant women were followed up until the end of the pregnancy to determine Congenital Rubella Syndrome, congenital infections and other pregnancy outcomes.
RESULTS: The median age of 685 enrolled pregnant women was 23 (IQR: 19-27) years. A total of 629(91.8%) were Rubella IgG seropositive while 61 (8.9%) were IgM seropositive. The IgM seropositivity was found to decrease significantly from first trimester to third trimester, p<0.001. Forty six (83.6%) of 55 Rubella IgM seropositive women had adverse pregnancy outcomes and 6 (10.9%) delivered neonates with CRS, making the overall incidence of CRS to be 6/685 (0.87%). First trimester IgM seropositive women had significantly higher adverse pregnancy outcomes than those in second/third trimesters (70.4% vs. 35.7, p=0.01).
CONCLUSION: There is one case of CRS in every 100 pregnancies necessitating additional strategies to reach a goal of elimination of CRS in developing countries.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acute Rubella; CRS; Pregnant women; Tanzania

Mesh:

Substances:

Year:  2018        PMID: 30391418     DOI: 10.1016/j.ijid.2018.10.020

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  The Burden of Likely Rubella Infection among Healthy Pregnant Women in Abakaliki, Ebonyi State, Nigeria.

Authors:  Uchechukwu Onyeukwu Ekuma; Ogbonnaya Ogbu; Angus Nnamdi Oli; Martin-Luther Oseni Okolo; Peter Anyigor Edeh; Hussein O M Al-Dahmoshi; Sousan Akrami; Morteza Saki
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-01-31

2.  Reduction in Rubella Virus Active Cases among Children and Adolescents after Rubella Vaccine Implementation in Tanzania: A Call for Sustained High Vaccination Coverage.

Authors:  Fausta Michael; Mariam M Mirambo; Dafrossa Lyimo; Furaha Kyesi; Delfina R Msanga; Georgina Joachim; Honest Nyaki; Richard Magodi; Delphius Mujuni; Florian Tinuga; Ngwegwe Bulula; Bonaventura Nestory; Dhamira Mongi; Ahmed Makuwani; Betina Katembo; William Mwengee; Alex Mphuru; Nassor Mohamed; David Kayabu; Helmut Nyawale; Eveline T Konje; Stephen E Mshana
Journal:  Vaccines (Basel)       Date:  2022-07-27

3.  Herpes Simplex Virus Type 2 (HSV-2) and Cytomegalovirus (CMV) among Women with Macerated Stillbirth: A Cross-Sectional Hospital-Based Study from Mwanza, Tanzania.

Authors:  Helmut A Nyawale; Elieza Chibwe; Fridolin Mujuni; Lidya Maiga; Albert Silvin; Alda Ester Chongo; Bertrand Msemwa; Vitus Silago; Mtebe Majigo; Doreen Kamori; Stephen E Mshana; Mariam M Mirambo
Journal:  J Pregnancy       Date:  2022-09-08

4.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.